Box score
General Oncology, Inc.
Reported $4.8M sold in a new Form D filed April 23, 2026 (Newton, Massachusetts).
- Biggest raise
- $4.8M filed Apr 23, 2026
- League
- Bio & Health Pharmaceuticals
- Based in
- Newton, Massachusetts
- Season rank
- #349 of 1,121 in the Bio & Health League; #2948 of 10,745 overall (2026)
- Entity
- Corporation
Form D filings since 2024 3
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-04-23 | New notice | $4.8M | $4.8M | SEC |
| 2025-07-02 | Amendment | $10.9M | $17.3M | SEC |
| 2024-07-02 | Amendment | $7.2M | $11.2M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1658021.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Enveric Biosciences, Inc. | Bio & Health | $5M |
| 2 | Fresenius Medical Care Northern Lancaster, LLC rookie | Bio & Health | $4.6M |
| 3 | 20 Bio, Inc. rookie | Bio & Health | $4.5M |
| 4 | Fresenius Medical Care Fulshear, LLC rookie | Bio & Health | $4.4M |
| 5 | Everest Biolabs, Inc. rookie | Bio & Health | $4.3M |
| 6 | Circinus Medical Technology LLC | Bio & Health | $4.2M |